Search details
1.
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis.
Neurol Sci
; 44(5): 1515-1532, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36648561
2.
Healthcare utilization and costs among patients with chronic migraine, episodic migraine, and tension-type headache enrolled in commercial insurance plans.
Headache
; 62(2): 141-158, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35156215
3.
Impact of emergency department opioid use on future health resource utilization among patients with migraine.
Headache
; 61(2): 287-299, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33599982
4.
Patterns and predictors of opioid use among migraine patients at emergency departments: A retrospective database analysis.
Cephalalgia
; 40(13): 1489-1501, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32781832
5.
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients.
Infect Dis Ther
; 12(7): 1849-1860, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37329414
6.
Real-world cost of care and site of care in patients with multiple sclerosis initiating infused disease-modifying therapies.
J Med Econ
; 26(1): 494-502, 2023.
Article
in English
| MEDLINE | ID: mdl-36970763
7.
Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic.
Mult Scler Relat Disord
; 78: 104881, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37556938
8.
Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression.
J Manag Care Spec Pharm
; 28(11): 1272-1281, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36282930
Results
1 -
8
de 8
1
Next >
>>